医学
节的
淋巴
肺癌
队列
阶段(地层学)
肺
人口
癌症
肿瘤科
内科学
放射科
外科
病理
生物
古生物学
环境卫生
作者
Vivek Verma,Steven H. Lin
出处
期刊:Translational cancer research
[AME Publishing Company]
日期:2016-11-30
被引量:1
标识
DOI:10.21037/tcr.2016.11.65
摘要
The management of early-stage non-small cell lung cancer (NSCLC) with clinically positive N1 lymph nodes (LNs) involves surgical resection if technically and medically feasible (1,2). Thereafter, many of these patients will be confirmed as pathologically N1, without involvement of N2 mediastinal nodal stations. However, it is well-recognized that N1 NSCLC represents a diverse and heterogeneous population, with varying rates of recurrence and survival (3). Hence, the goal of ongoing investigation has been to better delineate prognostic groups within this relatively ambiguous cohort, so as to optimally treat patients at various risk levels.
科研通智能强力驱动
Strongly Powered by AbleSci AI